Literature DB >> 14503564

The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis.

Moisés Selman1, Annie Pardo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14503564

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  30 in total

1.  Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.

Authors:  Xiaoyun Li; Sharon E Kim; Ting-Yun Chen; Juan Wang; Xia Yang; Tracy Tabib; Jiangning Tan; Brandon Guo; Sonia Fung; Jing Zhao; John Sembrat; Mauricio Rojas; Sruti Shiva; Robert Lafyatis; Claudette St Croix; Jonathan K Alder; Y Peter Di; Daniel J Kass; Yingze Zhang
Journal:  FASEB J       Date:  2020-06-28       Impact factor: 5.191

Review 2.  Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases.

Authors:  Sebastian Reuter; Hendrik Beckert; Christian Taube
Journal:  Lab Invest       Date:  2015-11-23       Impact factor: 5.662

3.  Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis.

Authors:  Mizuho Yamada; Kazuyoshi Kuwano; Takashige Maeyama; Naoki Hamada; Michihiro Yoshimi; Yoichi Nakanishi; Michael Kasper
Journal:  Histochem Cell Biol       Date:  2008-01-31       Impact factor: 4.304

Review 4.  Epithelial origin of myofibroblasts during fibrosis in the lung.

Authors:  Brigham C Willis; Roland M duBois; Zea Borok
Journal:  Proc Am Thorac Soc       Date:  2006-06

5.  Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Qiyuan Zhou; Tianji Chen; Wei Zhang; Melike Bozkanat; Yongchao Li; Lei Xiao; Richard B van Breemen; John W Christman; Jacob I Sznajder; Guofei Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

6.  Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis.

Authors:  Mizuho Yamada; Kazuyoshi Kuwano; Takashige Maeyama; Michihiro Yoshimi; Naoki Hamada; Jutaro Fukumoto; Kensuke Egashira; Kenichi Hiasa; Koichi Takayama; Yoichi Nakanishi
Journal:  J Clin Pathol       Date:  2006-10-03       Impact factor: 3.411

7.  Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition.

Authors:  Jeong Sup Song; Chun Mi Kang; Chan Kwon Park; Hyung Kyu Yoon; Sook Young Lee; Joong Hyun Ahn; Hwa-Sik Moon
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

Review 8.  The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Kevin K Brown
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

9.  Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study.

Authors:  Giorgos A Margaritopoulos; Katerina M Antoniou; Kostas Karagiannis; Katerina D Samara; Ismini Lasithiotaki; Evi Vassalou; Rena Lymbouridou; Helen Koutala; Nikos M Siafakas
Journal:  Fibrogenesis Tissue Repair       Date:  2010-10-11

10.  Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 transcriptional repressor.

Authors:  Xiaoying Liu; Robert J Kelm; Arthur R Strauch
Journal:  Mol Biol Cell       Date:  2009-03-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.